Biotechnology cancer Cancer Discovery Clinical Trials Existing drug could treat aggressive brain cancer By Staff Reports 1 year ago A research team from the University of Georgia’s Regenerative Bioscience Center has found that a
Biotechnology Cancer Discovery Cell Therapy Clinical Trials Yale Cancer Center finding offers hope for treatment of incurable Childhood Brain cancer By Staff Reports 1 year ago A team of investigators at Yale Cancer Center (YCC) have found a major chink in
Biotechnology cancer Clinical Trials drug development New drug shows encouraging survival in pancreatic cancer By Staff Reports 1 year ago A clinical trial testing a new drug in pancreatic cancer had promising initial results, report
Biotechnology cancer Cell Therapy Clinical Trials drug development Pancreatic Cancer: Less Toxic, More Enduring Drug May Improve Therapy By Staff Reports 1 year ago Unlike many other cancers, most pancreatic tumors are rock hard. “That’s one reason why pancreatic
Biotechnology cancer Clinical Trials A new choice for young women with pre-cancerous cervical disease By Staff Reports 1 year ago A single test for women has been shown to aid in predicting which cases of
cancer Clinical Trials drug development Immunotherapies Zhang group identifies gene that may make triple-negative breast cancer cells vulnerable to existing drug By Staff Reports 1 year ago Certain therapies that have proven effective in treating some types of breast cancers are ineffective
Biotechnology cancer Cancer Discovery Clinical Trials Targeting a Key Protein May Keep Ovarian Cancer Cells From Spreading By Staff Reports 1 year ago Preventing a protein from doing its job may keep a certain type of ovarian cancer
Biotechnology cancer Cell Therapy Clinical Trials Engineered Cell Evolution May Provide Pathway to Halting Cancer Drug Resistance By Staff Reports 1 year ago A significant problem when treating cancer patients remains drug resistance, which often causes chemotherapy treatments
Biotechnology cancer Clinical Trials Penn Researchers Influence CDC’s Clarification on Prescribing Opioids for Cancer Pain By Staff Reports 1 year ago To reduce the number of people who may misuse, abuse, or overdose from opioids, multiple
Biotechnology cancer Clinical Trials Immunotherapies Kidney disease UT Southwestern develops test to predict immunotherapy response in kidney cancer By Staff Reports 1 year ago A novel imaging test shows promise for identifying kidney cancer patients most likely to benefit
Biotechnology Clinical Trials New Investigational Therapy Shows Promise for Asthma Patients in Phase 2 Trial By Staff Reports 1 year ago NEW INVESTIGATIONAL THERAPY SHOWS PROMISE FOR ASTHMA PATIENTS IN PHASE 2 TRIAL Newswise — ATS
cancer Clinical Trials USC Norris Comprehensive Cancer Center launches study aimed at increasing diversity among clinical trial participants By Staff Reports 1 year ago USC Norris Comprehensive Cancer Center has launched a study to determine how financial assistance for
Biotech Company News cancer Clinical Trials Eureka Therapeutics Announces Us FDA Clearance of IND Application for Phase 1/2 Trial of Et140202 Artemis T-Cell Therapy, For The Treatment of Liver Cancer By Staff Reports 2 years ago Eureka Therapeutics, Inc., a clinical stage biotechnology company developing antibody-TCR (AbTCR) T-cell therapies, announced that
Clinical Trials Higher Risk of Fracture in Type 1 diabetes may be linked to poor Blood Sugar Control By Staff Reports 2 years ago Patients with type 1 diabetes and poor blood sugar control face a higher risk of
cancer Cancer Discovery Cancer screening Clinical Trials Early Clinical Trial Data Show Gene Therapy Reversing Sickle Cell Anemia By Staff Reports 2 years ago After over a decade of preclinical research and development, a new gene therapy treatment for
Biotechnology Cell Therapy Clinical Trials Immunotherapies stem cells Dana-Farber researchers report clinical trial results in treatment of leukemia and lymphoma By Staff Reports 2 years ago New results from clinical trials of immunotherapy and experimental targeted agents for patients with leukemia
Biotechnology Clinical Trials Research & Discovery WVU first site to launch clinical trial utilizing non-opioid micropellet implant for chronic pain By Staff Reports 2 years ago As part of an ongoing commitment to battle opioid addiction, the Rockefeller Neuroscience Institute at
Biotechnology cancer Clinical Trials Researchers Use New AI Techniques in Clinical Trials for Personalized Cancer Treatment By Staff Reports 2 years ago Researchers are finding new ways to use artificial intelligence and nanotechnology to enhance treatments, from
cancer Clinical Trials drug development Surgery Neoadjuvant Combination Checkpoint Blockade Trial Yields High Response Rates for Patients with High-Risk Stage 3 Melanoma By Staff Reports 2 years ago Combination checkpoint blockade before surgery (neoadjuvant therapy) produced a high response rate among patients with
Biotechnology Breast Cancer cancer Cancer Discovery Cancer screening Clinical Trials genes New Study Finds Nanoparticles Show Promise in Therapy for Triple-Negative Breast Cancer By Staff Reports 2 years ago Approximately 10-20 percent of diagnosed breast cancers are found to be triple-negative, meaning the breast